Efficacy and safety of HSK3486 vs. propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of anaesthesiology"
DOI: 10.1097/eja.0000000000001799
Abstract: BACKGROUND HSK3486 (ciprofol) is a 2,6-disubstituted phenol derivative that acts like propofol as an agonist at the gamma-aminobutyric acid-A (GABAA) receptor. OBJECTIVE To investigate the efficacy and safety of HSK3486 for general anaesthesia induction and… read more here.
Keywords: hsk3486; maintenance; trial; group ... See more keywords